DAAs
Senators Introduce Bill Aimed to Support Fight to Cure Hep C
A new bill introduced to the U.S. Senate aims to increase funding and access for hepatitis C virus treatment in the ...
JUNE 5, 2025
Most Americans With HCV Not Receiving DAAs
More than 2 million people in the United States have HCV, and most of them have not received direct-acting ...
AUGUST 8, 2023
Most Americans With HCV Not Receiving DAAs
More than 2 million people in the United States have hepatitis C virus, and most of them have not received ...
JUNE 30, 2023
Longer HCV Therapy Better for Coinfected HIV Patients
Although shorter treatment appears to work well in people with just HCV, those with HIV co-infection might need ...
MAY 29, 2019
Large Study Confirms DAAs Protect Against HCC When SVR Achieved
Patients with hepatitis C who are successfully treated with direct-acting antiviral agents experience a dramatic ...
MARCH 1, 2018
Payors Denying DAAs to More HCV Patients
An increasing number of patients with hepatitis C virus infection are being denied a lifesaving treatment by their ...
MAY 6, 2017
HCV Drugs May Slash Wait Times for Transplants
For a quarter of a century, organs from donors with HCV have been considered unusable for transplant. But now that ...
MARCH 8, 2017
FDA Issues Black Box Warning for HCV Drugs
The FDA is urging DAA manufacturers to place the warning labels on their drugs.
OCTOBER 6, 2016
